源自人乳的二乙基乳糖-N-四糖通过抑制PI3K/AKT介导的巨噬细胞促炎激活,有效预防坏死性小肠炎的发生。
Human milk-derived disialyllacto-N-tetraose protects against necrotizing enterocolitis by suppressing PI3K/AKT-mediated macrophage pro-inflammatory activation
Wenwei Jiang, Minyan Qian, Jinling Mo, Jiamin Dong, Dan Wang, Dong Zhou, Wenting Zhang
Journal:Journal of Functional Foods
IF:3.9
DOI:10.1016/j.jff.2026.107507
PMID:
Published:2026-09-12
research field:毒理学细胞生物学免疫学代谢组学环境健康
Abstract
Among ten HMOs, DSLNT is lower in NEC breast milk, reinforcing its biomarker role. • Integrative network analysis, molecular docking and 100 ns MD reveal PI3K/AKT as DSLNT target. • DSLNT inhibits macrophage oxidative stress, mitochondrial dysfunction, iNOS, p-AKT; reversed by 740Y-P via PI3K/AKT. Necrotizing enterocolitis (NEC) remains a leading cause of morbidity and mortality in preterm infants, and human milk oligosaccharides (HMOs) have emerged as bioactive components implicated in its prevention. Although reduced disialyllacto-N-tetraose (DSLNT) in maternal milk has been linked to NEC risk, the molecular mechanism by which DSLNT modulates intestinal inflammation remains poorly defined. UPLC-MS/MS quantification of ten representative HMOs in milk from mothers of full-term, preterm, and NEC infants revealed a reduction of DSLNT in the NEC group. An integrated strategy combining network pharmacology, KEGG enrichment analysis, molecular docking, and molecular dynamics simulations predicted the PI3K/AKT signaling pathway as a potential target of DSLNT. Functional validation in LPS/IFN-γ-stimulated RAW 264.7 macrophages demonstrated that DSLNT inhibited pro-inflammatory activation, alleviated oxidative stress, stabilized mitochondrial function, and suppressed iNOS expression as well as AKT phosphorylation; these protective effects were abrogated by the PI3K agonist 740Y-P. Mechanistic dissection further confirmed that DSLNT suppresses the activation of the PI3K/AKT pathway, thereby downregulating the expression of inflammatory mediators. Collectively, these findings support that DSLNT attenuates the inflammatory response through inhibition of the PI3K/AKT pathway in macrophages, providing a mechanistic rationale for its further evaluation as a therapeutic candidate. This study elucidates the protective mechanism of DSLNT against NEC by employing a comprehensive computational strategy to identify candidate targets and pathways. Systems pharmacology analysis first r
本文使用的Yeasen产品
南美超级胎牛血清999尝鲜特惠


